divers
technolog
current
avail
diseas
diagnost
laboratori
environ
cultur
remain
gold
standard
bacteriolog
diagnosi
despit
moder
sensit
timeconsum
expens
cultur
also
requir
specif
laboratori
infrastructur
well
train
oper
rapid
antigen
test
describ
provid
modest
diagnost
sensit
particularli
vaccin
popul
deliv
result
minut
rel
simpl
equip
less
expens
cultur
test
base
nucleic
acid
amplif
naat
pcr
avail
mani
infecti
diseas
pcr
techniqu
provid
high
accuraci
time
result
hour
allow
multianalyt
test
howev
techniqu
involv
perform
thermal
cycl
amplif
highprecis
instrument
equip
bulki
expens
complex
oper
requir
special
train
oper
stringent
condit
laboratori
compartment
factor
constrain
perform
pcr
central
laboratori
ideal
diagnost
test
meet
assur
criteria
afford
sensit
specif
userfriendli
rapid
robust
equipmentfre
deliv
need
access
qualityassur
diagnost
annual
report
less
us
per
test
less
us
per
devic
could
consid
afford
price
develop
countri
new
direct
explor
improv
access
rapid
simplic
diagnost
test
advanc
microfluid
miniatur
signal
detector
allow
integr
molecular
diagnost
microscal
labonachip
devic
perform
necessari
pcr
step
automat
sampl
intak
cell
lysi
dna
extract
purif
amplif
howev
continu
gap
firstgener
pcrbase
pointofcar
poc
test
ideal
assur
test
term
portabl
afford
instrument
requir
isotherm
dna
amplif
technolog
emerg
promis
driver
molecular
poc
diagnost
aim
meet
assur
attribut
techniqu
report
analyt
sensit
specif
compar
pcr
higher
toler
inhibitori
compound
allow
shorter
time
result
easier
use
chemistri
capabl
process
raw
sampl
directli
without
previou
dna
purif
thu
contribut
increas
simplic
addit
reduct
cost
time
although
current
isotherm
reagent
cheaper
pcr
isotherm
techniqu
avoid
use
bulki
complex
expens
devic
contrast
pcr
addit
techniqu
requir
dna
purif
allow
use
raw
sampl
therefor
isotherm
assay
pave
way
develop
introduct
inexpens
poc
devic
price
progress
tend
closer
later
flow
antigen
test
pcr
exampl
devic
detect
salmonella
pcr
taqman
salmonella
enterica
detect
kit
thermo
fisher
scientif
life
technolog
ca
usa
cost
us
wherea
devic
detect
pathogen
recombinas
polymeras
amplif
rpa
salmonella
kit
twistdx
cambridg
uk
estim
cost
us
also
remark
isotherm
techniqu
process
raw
sampl
skip
purif
step
reduc
us
total
cost
per
sampl
comparison
pcr
overal
isotherm
techniqu
potenti
make
perform
easier
bring
addit
save
labor
cost
divers
studi
describ
evolut
isotherm
molecular
techniqu
review
describ
stateoftheart
new
direct
develop
isotherm
amplif
technolog
diagnosi
infecti
diseas
particular
focu
suscept
integr
inexpens
molecular
poc
test
promis
techniqu
basic
design
state
develop
applic
classifi
discuss
also
provid
glimps
evolut
applic
near
futur
barrier
overcom
success
deploy
nucleic
acid
sequencebas
amplif
nucleic
acid
sequencebas
amplif
nasba
relat
techniqu
transcript
mediat
amplif
selfsustain
sequenc
replic
first
isotherm
amplif
reaction
mimick
retrovir
rna
replic
emerg
hiv
propel
develop
rapid
reliabl
hiv
detect
nasba
earli
dawn
isotherm
naat
nasba
base
three
differ
enzym
particip
amplif
process
supplementari
figur
supplementari
materi
found
onlin
wwwinformahealthcarecomsuppl
rang
current
commerci
nasba
test
cover
solut
integr
later
flow
format
method
name
oligochromatographi
fluoresc
detect
assay
tabl
among
nasba
test
panther
geneprob
system
tgri
devic
alreadi
avail
fulli
autom
process
sampl
result
howev
larg
volum
weight
well
long
time
consum
result
solut
character
assur
test
attempt
made
develop
poc
test
base
nasba
integr
system
combin
rna
purif
previous
extract
bacteria
nasba
amplif
detect
describ
detect
escherichia
coli
rna
recent
advanc
toward
samplein
answerout
nasba
poc
instrument
done
integr
preconcentr
nucleic
acid
extract
amplif
realtim
fluoresc
detect
singl
sampl
devic
strand
displac
amplif
sda
isotherm
amplif
method
combin
action
restrict
endonucleas
strand
displac
dna
polymeras
amplifi
dna
target
sequenc
supplementari
figur
amplif
reaction
take
place
low
astring
condit
produc
nonspecif
primer
bind
nonspecif
amplif
occur
case
nasba
mechan
especi
problemat
diagnost
devic
util
clinic
environ
sinc
sampl
contain
abund
human
dna
desir
target
addit
initi
amplif
time
h
make
sda
inadequ
poc
applic
present
laboratori
diagnost
devic
name
bd
probetec
tm
et
system
chlamydia
trachomati
neisseria
gonorrhoea
detect
commerci
bd
diagnost
nonetheless
devic
requir
intens
hand
labor
tabl
approach
sda
integr
poc
devic
done
develop
autom
instrument
combin
sampl
prepar
whole
cell
sda
detect
long
time
detect
h
obstacl
use
sda
assur
test
loopmedi
isotherm
amplif
lamp
one
wide
describ
onestep
amplif
techniqu
technolog
base
stranddisplac
activ
bst
dna
polymeras
avoid
continu
dna
amplif
reaction
four
primer
necessari
reaction
fipbip
figur
addit
lflb
primer
acceler
reaction
figur
pool
primer
combin
restrict
anneal
reaction
temperatur
make
reaction
highli
specif
allow
amplif
detect
scheme
min
common
templat
lamp
dna
rna
templat
could
also
detect
ad
revers
transcriptas
togeth
dna
polymeras
specif
variant
term
revers
transcriptas
loopmedi
isotherm
amplif
rtlamp
white
precipit
magnesium
pyrophosph
produc
lamp
reaction
allow
turbidimetr
detect
dna
amplif
qualit
visual
method
realtim
quantit
turbidimetri
sever
detect
method
intercal
fluoresc
dye
lamp
need
initi
denatur
allow
strand
separ
interest
characterist
poc
applic
nevertheless
higher
level
sensit
analyt
diagnost
obtain
includ
heat
denatur
detect
limit
low
one
copi
per
reaction
importantli
bst
dna
polymeras
use
lamp
reaction
show
high
toler
eiken
chemic
compani
tokyo
japan
develop
commerci
lamp
method
dna
rna
amplif
kit
target
laboratori
develop
homemad
techniqu
addit
compani
offer
varieti
kit
detect
human
pathogen
food
environ
salmonella
e
coli
listeria
monocytogen
campylobact
legionella
giardia
cryptosporidium
addit
eiken
chemic
collabor
foundat
innov
new
diagnost
hospit
tropic
diseas
recent
develop
fieldstabl
lamp
kit
malaria
detect
speci
human
malaria
parasit
valid
commerci
loopmedi
isotherm
amplif
assay
tblamp
detect
tuberculosi
recent
report
eiken
expect
launch
market
soon
togeth
kit
human
african
trypanosomiasi
lamp
technolog
also
implement
illumigen
meridian
bioscienc
cincinnati
oh
usa
assay
rapid
diagnosi
clostridium
difficil
mycoplasma
pneumonia
group
streptococcu
group
b
streptococcu
addit
amplex
biosystem
germani
commerci
eazyplex
superbug
detect
carbapenemas
antibiot
resist
cover
kpc
ndm
vim
acinetobact
baumannii
belong
oxagroup
like
like
like
eazyplex
superbug
cre
also
includ
esbl
gene
famili
test
take
min
result
also
interest
note
realtim
pcr
devic
use
isotherm
amplif
detect
although
less
complex
instrument
specif
aim
purpos
among
other
instrument
geni
ii
optigen
horsham
uk
instrument
geni
iii
allow
isotherm
amplif
detect
fluoresc
wherea
meridian
bioscienc
cincinnati
oh
detect
amplif
product
turbid
due
rapid
specif
robust
simpl
equip
possibl
process
almost
raw
sampl
lamp
suitabl
method
lowcost
poc
util
combin
technolog
microfluid
sinc
first
microfluid
disc
detect
hepat
b
viru
reach
analyt
sensit
copi
per
reaction
within
min
measur
turbid
signific
number
poc
devic
base
lamp
develop
multichannel
microfluid
devic
base
lamp
turbid
need
ml
detect
swine
viru
less
h
multiplex
microfluid
rtlamp
devic
abl
distinguish
three
type
influenza
substrain
detect
limit
copi
per
reaction
min
similar
way
colorimetr
devic
base
rtlamp
assay
report
detect
hepat
e
viru
visual
detect
limit
detect
copi
low
handl
equip
requir
last
year
complet
autom
poc
devic
term
microfluid
biomolecular
amplif
reader
report
process
raw
sampl
combin
molecular
microfluid
optic
electron
technolog
batterypow
instrument
use
light
emit
diod
phototransistor
abl
detect
integras
gen
min
recent
novel
microfluid
biochip
manufactur
integr
lamp
line
probe
assay
giant
magnetoresist
sensor
high
analyt
sensit
hepat
b
viru
detect
copi
per
ml
h
helicasedepend
amplif
hda
eleg
method
base
natur
dna
replic
mechan
without
need
denatur
step
like
pcr
origin
hda
process
perform
three
differ
protein
plu
polymeras
dna
helicas
unwind
dsdna
two
addit
protein
figur
nevertheless
new
thermost
helicas
tteuvrd
thermoanaerobact
tengcongenesi
abl
work
allow
specif
reaction
without
mutl
ssb
hda
amplif
usual
take
min
least
lowcopi
number
possibl
modif
optim
done
although
singl
set
primer
need
hda
multiplex
hda
applic
develop
far
duplexdetect
pathogen
n
gonorrhoea
staphylococcu
aureu
combin
hda
microarraybas
detect
detect
assay
four
differ
gene
organ
hda
compat
divers
detect
mechan
like
fluoresc
detect
electrochem
dna
detect
gold
nanoparticl
technolog
success
use
differ
type
sampl
includ
urin
stool
blood
plasma
biohelix
beverli
usa
develop
hda
technolog
commerci
divers
kit
end
point
realtim
hda
detect
isoamp
ii
univers
thda
isoamp
iii
univers
thda
kit
kit
aim
develop
homemad
techniqu
addit
best
cassett
type
ii
later
flow
detect
min
reach
stage
earli
commerci
sever
assay
develop
detect
exampl
aureu
later
flow
time
detect
min
howev
kit
herp
simplex
viru
detect
isoamp
hsv
biohelix
current
avail
market
tabl
andresen
et
al
develop
hdamicroarray
detect
n
gonorrhoea
aureu
h
singl
duplex
way
therefor
suitabl
simultan
detect
variou
pathogen
microarray
could
regard
first
fulli
integr
microfluid
devic
combin
sampl
prepar
realtim
hda
capabl
detect
genom
copi
nonetheless
method
improv
time
detect
pcr
techniqu
neither
devic
develop
mahalanabi
et
al
e
coli
detect
contrast
ramalingam
et
al
design
microfluid
devic
flow
capillar
absorb
pad
without
pump
valv
devic
allow
hda
realtim
detect
sarscoronaviru
min
addit
zhang
et
al
present
droplet
microfluid
integr
techniqu
isol
hda
amplif
detect
occur
chip
final
step
direct
freeelectr
pathogen
detect
done
combin
nearli
powerfre
nucleic
acid
extract
electricitypow
isotherm
amplif
assay
diarrhea
diagnosi
hda
seem
appropri
method
lowcost
poc
util
howev
rel
modest
detect
limit
copi
achiev
demand
improv
sensit
recombinas
polymeras
amplif
lowtemperatur
isotherm
amplif
method
use
three
protein
reaction
recombinas
protein
dna
polymeras
dnabind
protein
prevent
reanneal
rpa
facilit
amplif
min
figur
detect
method
intercal
dye
molecular
beacon
taqman
technolog
incompat
rpa
reason
detect
strategi
twistampexo
twistamp
fpg
develop
use
sequencespecif
probe
success
detect
less
copi
dna
within
min
document
rpa
assay
likewis
realtim
revers
transcript
recombinas
polymeras
amplif
assay
develop
fast
detect
footandmouth
diseas
viru
within
min
bovin
coronaviru
min
well
target
differ
virus
bacteria
biothreat
agent
twistdx
cambridg
uk
commerci
varieti
rpa
product
develop
end
point
realtim
assay
twisamp
twistamp
exo
probe
includ
primer
templat
suppli
user
compani
also
commerci
kit
detect
salmonella
l
monocytogen
campylobact
red
snapper
fish
determin
tabl
togeth
devic
perform
amplif
detect
like
isotherm
devic
twirla
tm
twista
portabl
realtim
fluoromet
novel
technolog
littl
background
rpa
howev
appear
one
fastest
amplif
techniqu
appeal
featur
adapt
poc
devic
regard
fulli
autom
chip
centrifug
disc
format
develop
lutz
et
al
devic
prestor
freezedri
rpa
reagent
describ
allow
detect
gene
meca
aureu
min
novel
develop
digit
rpa
slipchip
indic
rpa
may
potenti
fast
sensit
low
volum
nick
extens
amplif
reaction
near
base
isotherm
method
term
exponenti
amplif
reaction
exponenti
amplif
reaction
use
nickingenzym
nick
dna
target
expos
site
primer
anneal
allow
dna
amplif
minut
method
seem
strongli
limit
requir
nativ
restrict
flank
target
sequenc
amplifi
contrast
near
allow
amplif
target
ad
restrict
site
flank
region
one
strand
nick
near
compar
sda
avoid
requir
datpa
prevent
doublestrand
cleavag
near
meet
two
basic
criteria
desir
integr
poc
test
dna
denatur
need
higher
toler
inhibit
pcr
achiev
littl
known
near
technolog
although
first
report
describ
high
analyt
sensit
detect
n
gonorrhoea
c
trachomati
dna
copi
number
clavibactermichiganesi
ralstoniasolnacearum
copi
detect
level
time
result
within
min
roll
circl
amplif
rca
isotherm
method
base
strand
displac
dna
polymeras
abl
amplifi
continu
circular
ssdna
supplementari
figur
peculiar
featur
rca
uniqu
concaten
dna
molecul
result
product
reaction
allow
situ
amplif
characterist
could
interest
applic
mainten
cellular
morpholog
import
anoth
interest
applic
rca
ultrasensit
protein
detect
sandwich
immunoassay
intriguingli
spite
describ
almost
year
ago
rca
diagnost
test
target
pathogen
reach
market
yet
differ
approach
integr
rca
chip
perform
sato
et
al
creat
microchip
integr
oper
process
includ
rca
mahmoudian
et
al
combin
rca
amplif
follow
electrophoresi
labonachip
assay
vibrio
cholera
detect
less
min
reiss
et
al
perform
rca
flowthrough
system
allow
stretch
amplifi
product
visual
fluoresc
microscopi
novel
lampbas
smart
amplif
process
smap
technolog
confound
signal
mediat
amplif
rna
technolog
prime
enzym
similar
lamp
adopt
asymmetr
primer
design
use
distinguish
singl
nucleotid
polymorph
clone
differ
one
nucleotid
contrast
lamp
reaction
target
lower
ident
primer
design
flexibl
therefor
reaction
primer
could
anneal
wildtyp
singl
nucleotid
polymorph
variant
differ
amplif
pathway
two
prime
event
primer
prime
specif
selfprim
nonspecif
asymmetr
design
primer
allow
reduc
selfprim
event
contribut
backgroundwildtyp
amplif
product
specif
design
take
account
wildtyp
target
sequenc
could
differ
one
nucleotid
five
primer
requir
turnback
primer
tp
fold
primer
fp
boost
primer
bp
two
outer
primer
second
special
featur
use
thermusaquaticu
mut
enzym
scan
dna
identifi
review
informahealthcarecom
mismatch
singlenucleotid
sensit
figur
mut
find
mismatch
bind
irrevers
way
block
action
dna
polymeras
consequ
dna
amplif
asymmetr
primer
design
mut
allow
singlenucleotid
discrimin
featur
make
techniqu
use
singl
nucleotid
polymorph
identif
littl
inform
found
literatur
technolog
document
high
specif
also
high
analyt
sensit
three
copi
precis
design
primer
need
achiev
desir
specif
sensit
especi
relat
tp
primer
fp
primer
use
infecti
diseas
diagnosi
still
limit
first
progress
made
detect
pandem
flu
within
min
base
techniqu
coupl
revers
transcriptas
reaction
howev
far
know
kit
research
diagnost
util
commerci
yet
isotherm
chimer
primeriniti
amplif
nucleic
acid
ican
isotherm
method
around
base
primer
thermost
rnaseh
bcabest
dna
polymeras
stranddisplac
activ
chimer
primer
bind
ssdna
templat
initi
dsdna
denatur
heat
start
synthesi
new
dna
strand
strand
straightaway
nick
rnase
action
penultim
residu
allow
dna
amplif
repetit
cycl
primer
short
figur
amplif
product
gener
ican
technolog
detect
real
time
sensit
way
time
convent
pcr
method
least
detect
system
describ
simultan
detect
c
trachomati
n
gonorrhoea
luminesc
probe
case
analyt
sensit
copi
achiev
h
detect
approach
done
order
incorpor
technolog
poc
assay
semiautom
poc
test
abl
detect
spore
bacillu
subtili
fluoresc
describ
exampl
biolog
warfar
agent
detect
nonetheless
low
analyt
sensit
spore
long
time
detect
h
requir
improv
effect
poc
applic
anoth
poc
approach
icanchromatostrip
detect
salmonella
inva
document
higher
diagnost
sensit
standard
pcr
assay
n
gonorrhoea
test
kit
ican
ngqr
salmonella
detect
kit
dna
chip
ican
tm
dna
icanbas
product
commerci
takara
bio
otsu
japan
howev
ican
product
research
diagnost
use
avail
market
present
current
landscap
emerg
isotherm
diagnost
solut
infecti
diseas
cover
varieti
technolog
tabl
allow
amplif
dna
ssdna
dsdna
rna
previou
revers
transcriptas
step
interestingli
method
lamp
rca
produc
continu
concatemer
dna
strand
could
use
situ
detect
noteworthi
major
isotherm
techniqu
attribut
high
analyt
sensit
within
rang
copi
previou
studi
wherea
sda
ican
near
seem
less
sensit
nevertheless
sinc
evalu
perform
develop
stage
academ
laboratori
studi
precommerci
avail
product
undertaken
confirm
data
certain
techniqu
lamp
sda
hda
rpa
near
appear
show
midtohigh
toler
biolog
compound
allow
lowor
nonpretr
sampl
process
could
interest
characterist
poc
use
procedur
simplic
denatur
previous
need
step
technolog
obvious
pcr
sinc
heat
requir
dna
extract
denatur
moder
factor
may
facilit
integr
powerfre
poc
instrument
would
particularli
suitabl
use
remot
set
integr
isotherm
techniqu
poc
devic
offer
advantag
simpl
instrument
possibl
certain
technolog
process
raw
sampl
thu
reduc
cost
product
process
involv
howev
emerg
isotherm
nearpoc
poc
applic
reach
proofofconcept
stage
evalu
studi
need
determin
feasibl
commerci
interest
expect
around
poc
diseas
diagnost
increas
specif
exponenti
growth
nearpoc
poc
develop
base
pcr
isotherm
amplif
technolog
diagnosi
infecti
diseas
last
year
competit
advantag
isotherm
technolog
like
becom
refer
chemistri
futur
poc
applic
could
gradual
displac
pcrbase
solut
divers
isothermalbas
technolog
tack
technic
challeng
microscal
find
way
market
low
sampl
volum
handl
low
concentr
target
complex
signal
amplif
due
tabl
low
concentr
target
instabl
compat
integr
variou
devic
subsystem
identifi
major
hurdl
develop
poc
assay
appear
lamp
reach
higher
degre
matur
isotherm
techniqu
overcom
hurdl
accord
number
relat
develop
product
howev
technic
potenti
lamp
compet
chemistri
automat
guarante
futur
adopt
addit
valid
clinic
lab
obtain
solid
result
rang
cultur
organiz
econom
regulatori
barrier
may
undermin
success
deploy
diagnost
point
care
either
isotherm
base
technolog
one
main
challeng
effect
implement
upcom
year
gain
posit
percept
end
user
healthcar
provid
sinc
rapid
diagnosi
poc
assay
allevi
patient
anxieti
elimin
return
visit
result
appear
deliveri
diagnosi
site
well
accept
end
user
howev
accept
decentr
diagnost
healthcar
provid
impli
import
chang
clinic
practic
workload
logist
new
framework
need
design
point
contact
patient
healthcar
system
ensur
adequ
onsit
sampl
collect
test
perform
qualiti
control
result
similarli
protocol
commun
healthcar
center
public
health
agenc
put
place
result
poc
assay
properli
captur
regist
adequ
central
surveil
control
infecti
diseas
anoth
challeng
met
near
futur
establish
final
price
poc
test
accept
payer
term
low
cost
also
willing
pay
import
optim
cost
reagent
materi
system
mass
product
assembl
devic
compon
nonetheless
final
decis
purchas
poc
test
central
laboratori
test
strictli
test
cheapest
faster
rather
cost
test
need
provid
desir
clinic
benefit
hand
futur
widespread
use
poc
devic
constrain
nonharmon
regulatori
condit
commerci
poc
devic
divers
geograph
market
especi
western
countri
awar
unexpect
event
may
encourag
limit
evolut
toward
nearpati
diagnost
envis
two
scenario
initi
adopt
isotherm
poc
test
plausibl
within
timefram
year
core
laboratori
usual
locat
referr
hospit
industri
countri
presum
first
market
segment
penetr
environ
alreadi
familiar
perform
pcr
naat
easili
evalu
characterist
isotherm
poc
solut
current
method
minor
organiz
chang
may
need
implement
isotherm
assay
special
laboratori
fundament
prove
sensit
specif
compar
gold
standard
techniqu
patholog
complex
etiolog
preval
referr
hospit
demonstr
costeffect
also
requir
prior
adopt
ensur
sustain
diagnost
servic
poc
applic
would
best
valu
referr
hospit
could
assay
target
diagnosi
timecrit
chronic
highli
transmiss
infect
well
differenti
diagnosi
infect
common
symptom
differ
treatment
requir
complex
toxic
expens
therapi
midterm
time
poc
applic
may
abl
migrat
core
laboratori
area
within
referr
hospit
emerg
ward
intens
care
unit
beyond
secondlevel
hospit
primari
care
provid
maintain
diagnost
accuraci
rapid
costeffect
allow
use
nonspecif
train
personnel
second
scenario
implement
poc
test
next
year
global
health
market
estim
resourcelimit
countri
experienc
million
case
malaria
million
new
infect
hiv
million
case
reactiv
tb
million
case
bacteri
pneumonia
fact
simpl
inexpens
poc
test
base
antibodi
detect
close
assur
ideal
alreadi
avail
develop
countri
lateralflow
dipstick
format
ie
diagnosi
human
immunodefici
viru
infect
also
need
highlight
major
popul
develop
world
resid
remot
rural
area
patient
often
travel
long
distanc
primari
healthcar
set
thu
may
unabl
return
test
result
moreov
primari
care
infrastructur
may
poor
avail
train
technician
limit
electr
suppli
equip
refriger
storag
reagent
portabl
extrem
lowcost
easytous
isotherm
poc
test
provid
rapid
visual
readout
minim
instrument
reagent
stabl
room
temperatur
would
wide
accept
scenario
particular
expect
mobil
phone
preval
develop
world
becom
fundament
complement
poc
applic
sinc
contribut
capabl
batterypow
suppli
readout
connect
transmiss
result
big
size
global
health
market
urgent
need
access
diagnost
offer
attract
opportun
manufactur
abil
scale
poc
applic
reduc
price
margin
may
low
poorest
countri
poc
product
may
allow
profit
commerci
emerg
middleincom
countri
applic
target
infect
heavi
burden
global
health
match
occur
develop
countri
may
higher
potenti
success
short
term
author
acknowledg
support
seventh
framework
programm
european
union
grant
author
relev
affili
financi
involv
organ
entiti
financi
interest
financi
conflict
subject
matter
materi
discuss
manuscript
apart
disclos
includ
employ
consult
honoraria
review
informahealthcarecom
stock
ownership
option
expert
testimoni
grant
patent
receiv
pend
royalti
write
assist
util
product
manuscript
ideal
diagnost
test
meet
assur
criteria
afford
sensit
specif
userfriendli
rapid
robust
equipmentfre
deliv
need
current
pcrbase
devic
even
intend
applic
point
care
need
instrument
perform
thermal
cycl
amplif
step
limit
portabl
afford
molecular
isotherm
amplif
technolog
may
facilit
develop
electricityfre
nonor
minim
instrument
pointofcar
devic
could
particularli
suitabl
use
develop
countri
proofofconcept
studi
academ
laboratori
environ
report
isotherm
techniqu
similar
better
sensit
specif
rapid
pcr
assay
studi
real
field
condit
need
valid
promis
diagnost
characterist
isotherm
techniqu
loopmedi
isotherm
amplif
smart
amplif
process
signal
mediat
amplif
rna
technolog
helicasedepend
amplif
strand
displac
amplif
recombinas
polymeras
amplif
nick
extens
amplif
reaction
isotherm
techniqu
midhigh
toler
inhibitori
compound
allow
use
raw
sampl
without
pretreat
step
may
interest
featur
pcrbase
pointofcar
poc
test
isotherm
techniqu
loopmedi
isotherm
amplif
nick
extens
amplif
reaction
recombinas
polymeras
amplif
could
adequ
integr
poc
test
due
rapid
introduct
use
isotherm
poc
applic
need
meet
divers
organiz
econom
regulatori
challeng
success
adopt
central
laboratori
industri
countri
primari
health
center
resourcelimit
countri
plausibl
scenario
deploy
isotherm
poc
test
view
